Skip to main content
OpenTrials
Completed

NCT Number: NCT01549587

Oral Hygiene and Maternity Outcomes Multicenter Study (OHMOM)

This study will track changes in oral health in pregnant women. Subjects will be assigned to either regular oral care or advanced oral care and be given oral care products to use until they deliver. A comparison between the two groups (regular and advanced oral care) will be made to see if the oral care products impacted oral health and maternity variables.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Center for Women's Reproductive Health, Birmingham, Alabama, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • provide written informed consent prior to participation and be given a signed copy of the informed consent form;
  • be at least the age of legal consent;
  • be between 8 and 24 weeks of pregnancy;
  • have at least 20 natural teeth;
  • have moderate-to-severe gingivitis during pregnancy, including at least 30 intraoral sites with evidence of marginal gingival bleeding.

Exclusion criteria

  • evidence of multiple gestations;
  • history of HIV infection, AIDS, autoimmune disease, or diabetes other than gestational diabetes;
  • indication for use of antibiotic pre-medication prior to dental procedures;
  • systemic corticosteroid or immunosuppressive therapy within 1 month of Baseline;
  • severe periodontal disease, rampant untreated dental caries, or other oral conditions that necessitate immediate dental care;
  • ongoing dental care that in the opinion of the investigator could impact study participation;
  • a history of allergies or hypersensitivity to mouth rinse products containing CPC;
  • any disease or condition that in the opinion of the investigator could interfere with the safe completion of the study;
  • randomization to a treatment in study 2011001 during a prior pregnancy.

Treatment and study plan

0.243% sodium fluoride

Drug

dentifrice: brush thoroughly twice daily

Other names: Crest® Cavity Protection toothpaste

Toothbrush

Device

brush thoroughly twice daily

Other names: Oral-B® Indicator toothbrush, regular, soft

Dental Floss

Device

floss the whole mouth once daily

Other names: Oral-B® Essentials dental floss

0.454% stannous fluoride

Drug

dentifrice: twice daily brush thoroughly for 2 minutes

Other names: Crest® Pro-Health toothpaste

0.07% Cetylpyridinium chloride

Drug

mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily

Other names: Crest® Pro-Health Multi-Protection Mouth Rinse

Primary outcomes

  1. Change From Baseline in Löe-Silness Gingivitis Index

    Time frame: 3 months

    Score Criteria 0 Normal gingiva.

    • Mild inflammation - slight change in color, slight edema. No bleeding on probing.
    • Moderate inflammation - redness, edema, and glazing. Bleeding on probing.
    • Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.
  2. Change From Baseline in Löe-Silness Gingivitis Index

    Time frame: 2 months

    Score Criteria 0 Normal gingiva.

    • Mild inflammation - slight change in color, slight edema. No bleeding on probing.
    • Moderate inflammation - redness, edema, and glazing. Bleeding on probing.
    • Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.
  3. Change From Baseline in Löe-Silness Gingivitis Index

    Time frame: 1 month

    Score Criteria 0 Normal gingiva.

    • Mild inflammation - slight change in color, slight edema. No bleeding on probing.
    • Moderate inflammation - redness, edema, and glazing. Bleeding on probing.
    • Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.

Secondary outcomes

  1. Gestational Age (Weeks)

    Time frame: At delivery

    log[42.9-gestational age]

Other outcomes

  1. Neonate Birth Weight (Grams)

    Time frame: At delivery

  2. Preterm Birth (Gestational Age < 37 Weeks)

    Time frame: At delivery

Sponsors and collaborators

Lead sponsor

Procter and Gamble

Industry

Registry information

Official study title

A Randomized Controlled Clinical Trial to Evaluate Late First to Mid-Second Trimester Introduction of Advanced Daily Oral Hygiene on Gingivitis and Maternity Outcomes

Acronym: OHMOM

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Mar 9, 2012
Registry last updated
Apr 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.